[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335155-105":59,"doc-detail-335155-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comparing-clinical-and-genomic-features-based-on-the-tumor-location-in-patients-with-resected-pancreatic-cancer","Comparing clinical and genomic features based on the tumor location in patients with resected pancreatic cancer","","Retrospective analysis evaluated whether tumor location drives differences in clinical outcomes and pancreatic ductal adenocarcinoma (PDAC) tumor biology. The study assessed 800 resected patients after upfront curative-intent surgery, with Cox regression testing the prognostic impact of pancreatic head versus body/tail location. Genomic profiling was performed in 153 patients with adequate tissue and blood samples. Survival and tumor biology showed no significant location-associated differences across multivariate and genomic analyses, including mutational landscapes, transcriptomic subtype distributions, and immune infiltration estimates.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comparing-clinical-and-genomic-features-based-on-the-tumor-location-in-patients-with-resected-pancreatic-cancer/335155/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comparing-clinical-and-genomic-features-based-on-the-tumor-location-in-patients-with-resected-pancreatic-cancer/335155.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How is pancreatic cancer location categorized in this study?","Question",{"text":112,"@type":113},"The study divides pancreatic cancer anatomy into pancreatic head and body/tail cancers, then compares outcomes and tumor biology between these locations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What method was used to evaluate the prognostic impact of tumor location?",{"text":117,"@type":113},"Cox regression analysis was used to explore how tumor location influenced survival outcomes among resected PDAC patients.",{"name":119,"@type":110,"acceptedAnswer":120},"What did genomic analyses show regarding differences between head and body/tail cancers?",{"text":121,"@type":113},"In the genomic cohort, no significant differences were found in mutational landscapes, transcriptomic subtype distribution, or estimated immune cell infiltration levels between head and body/tail tumors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335155,1790198226,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Yun etal. BMC Cancer (2024) 24:1048 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-12795-5](https://doi.org/10.1186/s12885-024-12795-5)  \nRESEARCH Open Access  \nComparing clinical and genomic features based on the tumor location in patients with resected pancreatic cancer  \nWon-Gun Yun 1, Daeun Kim2,3, Mirang Lee 1, Youngmin Han 1, Yoon Soo Chae 1, Hye-Sol Jung 1, Young Jae Cho 1, Wooil Kwon 1, Joon Seong Park 1, Daechan Park2,4 and Jin-Young Jang 1*  \nAbstract  \nBackground Pancreatic cancer is anatomically divided into pancreatic head and body/tail cancers, and some studies have reported differences in prognosis. However, whether this discrepancy is induced from the difference of tumor biology is hotly debated. Therefore, we aimed to evaluate the differences in clinical outcomes and tumor biology depending on the tumor location.  \nMethods In this retrospective cohort study, we identified 800 patients with pancreatic ductal adenocarcinoma who had undergone upfront curative-intent surgery. Cox regression analysis was performed to explore the prognostic impact of the tumor location. Among them, 153 patients with sufficient tumor tissue and blood samples who provided informed consent for next-generation sequencing were selected as the cohort for genomic analysis.  \nResults Out of the 800 patients, 500 (62 . 5%) had pancreatic head cancer, and 300 (37 . 5%) had body/tail cancer. Tumor location in the body/tail of the pancreas was not identified as a significant predictor of survival outcomes compared to that in the head in multivariate analysis (hazard ratio, 0 . 94; 95% confidence interval, 0 .77–1. 14; P = 0 . 511) . Additionally, in the genomic analyses of 153 patients, there were no significant differences in mutational landscapes, distribution of subtypes based on transcriptomic profiling, and estimated infiltration levels of various immune cells between pancreatic head and body/tail cancers.  \nConclusions We could not find differences in prognosis and tumor biology depending on tumor location in pancreatic ductal adenocarcinoma. Discrepancies in prognosis may represent a combination of lead time, selection bias, and clinical differences, including the surgical burden between tumor sites.  \nKeywords Pancreatic neoplasms, Tumor location, Prognosis, DNA mutation analysis, Molecular subtype, Tumor microenvironment  \n*Correspondence: Jin-Young Jang [jangjy4@snu.ac.kr](jangjy4@snu.ac.kr)  \n1Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea  \n2Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea  \n3Ajou Energy Science Research Center, Ajou University, Suwon 16499, Republic of Korea  \n4Advanced College of Bio-Convergence Engineering, Ajou University, Suwon 16499, Republic of Korea  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless ","cbCaigaA1Yhjbkt8","https://ap.wps.com/l/cbCaigaA1Yhjbkt8","pdf",3494224,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"How is pancreatic cancer location categorized in this study?\",\"answer\":\"The study divides pancreatic cancer anatomy into pancreatic head and body/tail cancers, then compares outcomes and tumor biology between these locations.\"},{\"question\":\"What method was used to evaluate the prognostic impact of tumor location?\",\"answer\":\"Cox regression analysis was used to explore how tumor location influenced survival outcomes among resected PDAC patients.\"},{\"question\":\"What did genomic analyses show regarding differences between head and body/tail cancers?\",\"answer\":\"In the genomic cohort, no significant differences were found in mutational landscapes, transcriptomic subtype distribution, or estimated immune cell infiltration levels between head and body/tail tumors.\"}]","Comparing clinical and genomic features based on the tumor location in patients with resected pancreatic cancer | PDF",1790009816]